ATE463242T1 - Behandlung von inkontinenz - Google Patents

Behandlung von inkontinenz

Info

Publication number
ATE463242T1
ATE463242T1 AT08160836T AT08160836T ATE463242T1 AT E463242 T1 ATE463242 T1 AT E463242T1 AT 08160836 T AT08160836 T AT 08160836T AT 08160836 T AT08160836 T AT 08160836T AT E463242 T1 ATE463242 T1 AT E463242T1
Authority
AT
Austria
Prior art keywords
incontinence
treatment
gamma
instant invention
aminobutyric acid
Prior art date
Application number
AT08160836T
Other languages
English (en)
Inventor
Catherine Segal
Leslie Magnus
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE463242(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE463242T1 publication Critical patent/ATE463242T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
AT08160836T 1999-04-08 2000-01-27 Behandlung von inkontinenz ATE463242T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12834799P 1999-04-08 1999-04-08

Publications (1)

Publication Number Publication Date
ATE463242T1 true ATE463242T1 (de) 2010-04-15

Family

ID=22434891

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00905786T ATE413872T1 (de) 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz
AT08160836T ATE463242T1 (de) 1999-04-08 2000-01-27 Behandlung von inkontinenz

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00905786T ATE413872T1 (de) 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz

Country Status (13)

Country Link
EP (2) EP1171114B1 (de)
JP (1) JP2002541198A (de)
KR (1) KR20010103053A (de)
AT (2) ATE413872T1 (de)
AU (2) AU779262B2 (de)
CA (1) CA2362026A1 (de)
DE (2) DE60040784D1 (de)
ES (2) ES2313880T3 (de)
HU (1) HUP0200738A3 (de)
IL (1) IL145763A0 (de)
TR (1) TR200102837T2 (de)
WO (1) WO2000061135A1 (de)
ZA (1) ZA200107425B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PT1572173E (pt) * 2002-12-13 2010-05-10 Warner Lambert Co Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
CA2510292A1 (en) * 2002-12-20 2004-07-15 Dynogen Pharmaceuticals, Inc. Methods of treating non-painful bladder disorders using .alpha.2.delta. subunit calcium channel modulators
EP1621193A3 (de) * 2002-12-20 2006-08-02 Dynogen Pharmaceuticals Inc. Behandlung nicht-schmerzhafter Blasenstörungen mit Kalziumkanalmodulatoren der alpha2-delta-Untereinheit
KR100742001B1 (ko) * 2003-03-21 2007-07-23 다이노젠 파마세우티컬스, 인코포레이티드 평활근 모듈레이터 및 알파2 델타 서브유닛 칼슘 채널모듈레이터를 이용한 하부 요로 질환의 치료 방법
CA2537837A1 (en) * 2003-09-11 2005-03-24 Xenoport, Inc. Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
CA2541752C (en) 2003-10-14 2012-01-03 Xenoport, Inc. Crystalline form of gamma-aminobutyric acid analog
CN102058885B (zh) * 2006-12-22 2013-04-10 瑞蔻达蒂爱尔兰有限公司 采用α2δ配体和NSAID的下泌尿道疾病的联合治疗
EP2240158A2 (de) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilisierte injizierbare pregabalin-formulierung
WO2009094563A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
CA2710538A1 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009560A1 (en) * 1990-11-27 1992-06-11 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
DK0641330T3 (da) * 1992-05-20 2001-12-03 Univ Northwestern Gaba- og L-glutaminsyreanaloger til antikrampeanfaldsbehandling
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) * 1998-12-15 2002-04-18 Kenneth A. Jones Dna encoding a gaba b r2 polypeptide and uses thereof

Also Published As

Publication number Publication date
WO2000061135A1 (en) 2000-10-19
HUP0200738A3 (en) 2003-03-28
AU2741600A (en) 2000-11-14
EP1977745B1 (de) 2010-04-07
DE60040784D1 (de) 2008-12-24
AU779262C (en) 2000-11-14
ZA200107425B (en) 2003-02-26
HUP0200738A2 (hu) 2002-07-29
CA2362026A1 (en) 2000-10-19
EP1977745A1 (de) 2008-10-08
ATE413872T1 (de) 2008-11-15
EP1171114B1 (de) 2008-11-12
EP1171114A1 (de) 2002-01-16
ES2313880T3 (es) 2009-03-16
ES2341059T3 (es) 2010-06-14
TR200102837T2 (tr) 2002-03-21
IL145763A0 (en) 2002-07-25
AU2005200619A1 (en) 2005-03-10
JP2002541198A (ja) 2002-12-03
KR20010103053A (ko) 2001-11-17
AU779262B2 (en) 2005-01-13
DE60044160D1 (de) 2010-05-20

Similar Documents

Publication Publication Date Title
DE60044160D1 (de) Behandlung von Inkontinenz
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
EP1017402A4 (de) Behandlung des übersäuerten darmsyndroms
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
DK0934061T3 (da) Isobutylgaba og dets derivater til behandling af smerte
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
DE60138129D1 (de) Apparat zur behandlung von zähnen
TR199800849T2 (xx) Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
DE60212613D1 (de) Doxycyclin zur behandlung von akne
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DE69613693D1 (de) 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
DE60219614D1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
DE69837564D1 (de) Azaheterozyklischederivate zur behandlung von haarausfall und neurologischer krankheiten
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
FI864246A0 (fi) N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DE60039601D1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
ATE125704T1 (de) Behandlung neurodegenerativer erkrankungen.
DE60111620D1 (de) Aktiviertes protein c zur behandlung von pankreatitis
DE69736180D1 (de) Behandlung von manischen erkrankungen
DE60110748D1 (de) Behandlung von fluorkohlenstoff-beschickungen
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE332697T1 (de) Cyanidinmischung zur behandlung von dickdarmkrebs
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties